EDGAR Filing Documents for 0001477932-20-002221

Form 8-K - Current report:

SEC Accession No. 0001477932-20-002221

Filing Date

2020-04-28

Accepted

2020-04-28 09:30:22

Documents

Period of Report

2020-04-27

Items

Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	ipix_8k.htm	8-K	13328
2	PRESS RELEASE	ipix_ex991.htm	EX-99.1	11359
	Complete submission text file	0001477932-20-002221.txt		25964

Mailing Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880

Business Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880 978-921-4125

Innovation Pharmaceuticals Inc. (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 300565645 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37357 | Film No.: 20822633
SIC: 2834 Pharmaceutical Preparations